The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Consulting or Advisory Role - ERYTECH Pharma; Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
Initial efficacy of anti-lymphocyte activation gene-3 (anti–LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti–PD-1/PD-L1 therapy.
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Ignacio Melero
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; Lilly; Roche
Research Funding - Bristol-Myers Squibb; Pfizer; Roche
Travel, Accommodations, Expenses - Genentech; Roche
 
Shailender Bhatia
Honoraria - Genentech/Roche
Consulting or Advisory Role - EMD Serono; Genentech/Roche
Research Funding - Bristol-Myers Squibb (Inst); Conkwest (Inst); EMD Serono (Inst); Immune Design (Inst); Merck (Inst); NantWorks; OncoSec (Inst)
Travel, Accommodations, Expenses - EMD Serono; NantWorks
 
Petri Bono
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Orion; Pfizer
Research Funding - Novartis
 
Rachel E. Sanborn
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; ARIAD; Genentech/Roche; Peregrine Pharmaceuticals; Seagen
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Evan J. Lipson
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Castle Biosciences; EMD Serono; Merck; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - METHOD OF PREVENTING ORGAN TRANSPLANT REJECTIONS USING AGONISTS TO THE PD-1 CHECKPOINT PATHWAY (Inst)
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I); Celgene (I); Kleo Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca; Moderna Therapeutics
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Clinical Care Options; Potomac Center for Medical Education
 
Thomas Gajewski
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; FORMA Therapeutics; Jounce Therapeutics; Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Licensing to Evelo (Inst)
 
Carlos A. Gomez-Roca
No Relationships to Disclose
 
F. Stephen Hodi
Employment - Dana-Farber Cancer Institute
Consulting or Advisory Role - Amgen; EMD Serono; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Giuseppe Curigliano
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Marta Nyakas
Consulting or Advisory Role - Amgen; Nordic/Norwegian Advisory Board MSD; Novartis
 
Matthias Preusser
Honoraria - GlaxoSmithKline; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; CMC Contrast; Gerson Lehrman Group; GlaxoSmithKline; Mundipharma; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche
 
Yoshinobu Koguchi
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Agonox
 
Matthew Maurer
No Relationships to Disclose
 
Raphael Clynes
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Priyam Mitra
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Satyendra Suryawanshi
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Eva Muñoz-Couselo
No Relationships to Disclose